Pregled bibliografske jedinice broj: 1147011
FibroScan-ast score predicts 30-day mortality or need for mechanical ventilation among patients hospitalized with COVID-19
FibroScan-ast score predicts 30-day mortality or need for mechanical ventilation among patients hospitalized with COVID-19 // Journal of clinical medicine, 10 (2021), 19; 4355, 12 doi:10.3390/jcm10194355 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1147011 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
FibroScan-ast score predicts 30-day mortality or
need for mechanical ventilation among patients
hospitalized with COVID-19
Autori
Zelenika, Marko ; Lucijanić, Marko ; Bokun, Tomislav ; Božin, Tonći ; Barišić Jaman, Mislav ; Tješić Drinković, Ida ; Paštrović, Frane ; Madir, Anita ; Lukšić, Ivica ; Piskač Živković, Nevenka ; Luetić, Krešimir ; Krznarić, Željko ; Ostojić, Rajko ; Filipec Kanižaj, Tajana ; Bogadi, Ivan ; Virović Jukić, Lucija ; Kukla, Michal ; Grgurević, Ivica
Izvornik
Journal of clinical medicine (2077-0383) 10
(2021), 19;
4355, 12
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
COVID-19 ; liver ; non-alcoholic steatohepatitis ; transient elastography ; mortality
Sažetak
Background: Liver involvement in Coronavirus disease 2019 (COVID-19) has been recognised. We aimed to investigate the correlation of non- invasive surrogates of liver steatosis, fibrosis and inflammation using transient elastography (TE) and FibroScan-AST (FAST) score with (a) clinical severity and (b) 30-day composite outcome of mechanical ventilation (MV) or death among patients hospitalized due to COVID-19. Method: Patients with non-critical COVID-19 at admission were included. Liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) were assessed by TE. Clinical severity of COVID-19 was assessed by 4C Mortality Score (4CMS) and need for high-flow nasal cannula (HFNC) oxygen supplementation. Results: 217 patients were included (66.5% males, median age 65 years, 4.6% with history of chronic liver disease). Twenty- four (11.1%) patients met the 30-day composite outcome. Median LSM, CAP and FAST score were 5.2 kPa, 274 dB/m and 0.31, respectively, and neither was associated with clinical severity of COVID-19 at admission. In multivariate analysis FAST > 0.36 (OR 3.19, p = 0.036), 4CMS (OR 1.68, p = 0.002) and HFNC (OR 7.03, p = 0.001) were independent predictors of adverse composite outcome. Conclusion: Whereas LSM and CAP failed to show correlation with COVID-19 severity and outcomes, FAST score was an independent risk factor for 30- day mortality or need for MV.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
KBC "Sestre Milosrdnice",
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Profili:
Rajko Ostojić
(autor)
Nevenka Piskać Živković
(autor)
Anita Madir
(autor)
Tomislav Bokun
(autor)
Mislav Barišić-Jaman
(autor)
Lucija Virović Jukić
(autor)
Frane Paštrović
(autor)
Željko Krznarić
(autor)
Krešimir Luetić
(autor)
Tajana Filipec Kanižaj
(autor)
Ivica Lukšić
(autor)
Marko Lucijanic
(autor)
Ivica Grgurević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus